|
[Related PubMed/MEDLINE] Total Number of Papers: 900
|
|
|
[Display Entries]
|
>> all entries
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Altered Ocular Surface Health Status and Tear Film Immune Profile Due to Prolonged Daily Mask Wear in Health Care Workers. |
OSDI, OSI, ST1 |
2 |
2022 |
Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops®). |
--- |
3 |
2022 |
Analysis of the Association between Galectin-3 Concentration in Tears and the Severity of Dry Eye Disease: A Case-Control Study. |
DED, FL, gal-3, LG |
4 |
2022 |
Anterior Segment-Optical Coherence Tomography and Diabetic Retinopathy: could it be an Early Biomarker? |
AS-OCT, BCVA, CET, CST, CT, IOP |
5 |
2022 |
Application of e-PTFE Frontalis Suspension in the Treatment of Congenital Ptosis in Children. |
CFS, ePTFE, LRH, MRD, STI |
6 |
2022 |
Assessment of dry eye disease in N95 versus surgical face mask wearers during COVID-19. |
DED, MGL, OSDI |
7 |
2022 |
Autologous platelet-rich plasma eye drop versus artificial tear eye drop for symptomatic dry eye disease: A prospective comparative interventional study. |
aPRP, AT, CFS, DED, OSDI |
8 |
2022 |
Bacterial distribution on the ocular surface of patients with primary Sjögren's syndrome. |
OS, OSS, SS |
9 |
2022 |
Capsanthin from Capsicum annum fruits exerts anti-glaucoma, antioxidant, anti-inflammatory activity, and corneal pro-inflammatory cytokine gene expression in a benzalkonium chloride-induced rat dry eye model. |
BAC, CCA, DED, GPx, IOP, LTF, MMP-9, NO, ODDS, PTGS2, TNF-alpha |
10 |
2022 |
Clinical Efficacy of an Eyedrop Containing Hyaluronic Acid and Ginkgo Biloba in the Management of Dry Eye Disease Induced by Cataract Surgery. |
DED, HA-GB, OSDI |
11 |
2022 |
Comparative Clinicopathological Evaluation of the Ocular Surface in Newly Diagnosed Patients of Hyperthyroidism and Hypothyroidism Compared to Healthy Subjects. |
PFH |
12 |
2022 |
Comparison of Consecutive Therapeutic Effects of Nanoemulsion and Emulsion Cyclosporin in Dry Eye Patients after Short-Term Treatment with Topical Fluorometholone. |
CSS, FML, MG, MGD, SANDE |
13 |
2022 |
Compliance with Lid Hygiene in Patients with Meibomian Gland Dysfunction. |
MGD |
14 |
2022 |
Conjunctival Impression Cytology and Tear Function in Patients with Keratoconus. |
CIC, OSDI, OSS |
15 |
2022 |
Correlation between tear film lipid layer thickness and transepidermal water loss from the ocular area in patients with dry eye disease and in healthy controls. |
MGD, NEI, OSDI, TEWL, VAS |
16 |
2022 |
Correlations between clinical parameters of dry eye disease and serologic profiles in Sjögren's syndrome. |
DED, LLT, OSS, pSS, RF |
17 |
2022 |
Correlations Between Single-Photon Emission Computed Tomography Parameters of Salivary Glands and Dry Eye Tests in Patients With Sjögren's Syndrome. |
CFS, EF, SIT, SPECT, SS, UI |
18 |
2022 |
Demodex folliculorum Infestation in Meibomian Gland Dysfunction Related Dry Eye Patients. |
D. folliculorum, MGD, OSDI, SIT |
19 |
2022 |
Does the conjunctivochalasis accompanied by pseudoexfoliation syndrome affect the ocular surface and anterior segment structures? |
AS, OS, OSDI, PES |
20 |
2022 |
Dry Eye Disease in Patients With Schizophrenia: A Case-Control Study. |
DED, G-CSF, ICAM-1, IL, LLT, M-SDS, MGL, MMP-9, OSDI, PBR, TIMP-1 |
21 |
2022 |
Effect of artificial tears on dynamic optical quality in patients with dry eye disease. |
DED, LLT, MTF cut-off, OQAS, OSDI, SD-OSI |
22 |
2022 |
Effect of facemasks on the tear film during the COVID-19 pandemic. |
OSDI |
23 |
2022 |
Effect of intense pulsed light using acne filter on eyelid margin telangiectasia in moderate-to-severe meibomian gland dysfunction. |
IPL, MGD, MMP, SICCA |
24 |
2022 |
Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial. |
FCS, LGCS, LLLT, MGD, OSDI |
25 |
2022 |
Effect of oral vitamin D supplementation on dry eye disease patients with vitamin D deficiency. |
DED |
26 |
2022 |
Effect of thermoelectric warming therapy for the treatment of Meibomian Gland Dysfunction. |
BCVA, DED, MGD |
27 |
2022 |
Effectiveness of acupuncture at acupoint BL1 (Jingming) in comparison with artificial tears for moderate to severe dry eye disease: a randomized controlled trial. |
AT, CFS, DED, NRS, OSDI, SIT |
28 |
2022 |
Effects of Intravitreal Injection on Ocular Surface and Anterior Segment Parameters. |
OSDI, VEGF |
29 |
2022 |
Effects of Medium-Term Soft Contact Lens Fitting on Dry Eye: Analyses Using Ultra-High Resolution Optical Coherence Tomography and Digital Slit-Lamp Biomicroscopy. |
DSLB, OSDI, SCLs, UHR-OCT |
30 |
2022 |
Effects of systemic anti-androgen drugs on the ocular surface. |
OSDI |
31 |
2022 |
Effects of the Topical Use of the Natural Antioxidant Alpha-Lipoic Acid on the Ocular Surface of Diabetic Patients with Dry Eye Symptoms. |
ALA, HPMC, OSDI |
32 |
2022 |
Effects of Upper Eyelid Surgery on the Ocular Surface and Corneal Topography |
--- |
33 |
2022 |
Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction. |
CsA, MG, MGD, OSDI |
34 |
2022 |
Evaluating the topographical measurements and tear function status in patients with hemifacial spasm: A comparative fellow eye study. |
HFS, SA, THOA |
35 |
2022 |
Evaluations of wavefront aberrations and corneal surface regularity in dry eye patients measured with OPD Scan III. |
CFS, DE, HOA, OSDI, ROC, SA, SAI, SDP, SRI |
36 |
2022 |
Global improvement in meibomian glands after chalazion surgery demonstrated by meibography. |
MGD, OSDI |
37 |
2022 |
Impact of Air Pollution on the Ocular Surface and Tear Cytokine Levels: A Multicenter Prospective Cohort Study. |
CFS, CI, DED, IL-8, MG, OSDI, PM, PM10, PM2.5, ST, TMH |
38 |
2022 |
Impact of Perioperative Dry Eye Treatment with Rebamipide Versus Artificial Tears on Visual Outcomes After Cataract Surgery in Japanese Population. |
CDVA, HOAs, IOL |
39 |
2022 |
Impact of Taping The Upper Mask Edge On Ocular Surface Stability and Dry Eye Symptoms. |
LLT, NIBUT, TMH |
40 |
2022 |
Impact of tear optics on the repeatability of Pentacam AXL wave and iTrace in measuring anterior segment parameters and aberrations. |
CoV, ICC, LOA, OSI, RMS HOA, Sw, TRT |
41 |
2022 |
Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study. |
BL, DED, FU, IPL, MGD, MGX, VAS |
42 |
2022 |
Intense pulsed light treatment of the upper and lower eyelids in patients with moderate-to-severe meibomian gland dysfunction. |
IPL, MGD, MMP-9 |
43 |
2022 |
Inter-Eye Comparison of the Ocular Surface of Glaucoma Patients Receiving Surgical and Medical Treatments. |
TFO, Trab Eye |
44 |
2022 |
Lipidomics Profiles Revealed Alterations in Patients With Meibomian Gland Dysfunction After Exposure to Intense Pulsed Light. |
CF, IPL, MGD, MGE, OSDI |
45 |
2022 |
Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome. |
COCS, MMP-9, SJS |
46 |
2022 |
Meibomian Gland Density: An Effective Evaluation Index of Meibomian Gland Dysfunction Based on Deep Learning and Transfer Learning. |
AI, AUC, MG, MGD, OSDI |
47 |
2022 |
Ocular Abnormalities in Patients with Vitiligo: A Systematic Review and Meta-Analysis. |
MD, NOS, OSDI |
48 |
2022 |
Ocular findings in patients with vitiligo: A single-center experience. |
VASI, VIDA |
49 |
2022 |
Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis. |
CCT, GC-IP, MGE, NIH, OSDI, RNFL, WMD |
50 |
2022 |
Ocular Surface Diseases in Patients With Diabetes. |
Hb, OSDI, TFMH |
51 |
2022 |
Oral vitamin D3 supplementation for femtosecond LASIK-associated dry eye vitamin D for LASIK dry eye syndrome. |
FS-LASIK, OSDI |
52 |
2022 |
Preoperative dry eyes disease in cataract patients with deficient tear break up time: evaluation of OSDI questionnaire, its subcategories and Keratograph 5M device results. |
DED, ET, OS, OSDI, TMH, VA, VFR |
53 |
2022 |
Prevalence and risk factors associated with dry eye disease among adults in a population-based setting in South-West Nigeria. |
DED |
54 |
2022 |
Prevalence, Severity, and Treatment Outcomes of Meibomian Gland Dysfunction in Patients With Dry Eye Symptoms at a Tertiary Care Center in South India. |
DED, MGD, OSDI |
55 |
2022 |
Psoriasis and Dry Eye Disease: A Systematic Review and Meta-Analysis. |
OSDI |
56 |
2022 |
Relation between dry eye and myopia based on tear film breakup time, higher order aberration, choroidal thickness, and axial length. |
AL, CT, DED, HOAs |
57 |
2022 |
Safety and Efficacy of Oral Supplementation of Lentil (Lens culinaris Medic) in Dry Eye Patients. |
LogMAR |
58 |
2022 |
Semiautomated and Automated Quantitative Analysis of Corneal Sub-Basal Nerves in Patients With DED With Ocular Pain Using IVCM. |
AUC, CNBD, CNFD, CNFL, DED, ICC, IVCM, OPAS, OSDI, SNP |
59 |
2022 |
Sleep Quality Is Associated With Severe Meibomian Gland Disruption in Dry Eye. |
AIS, DED, NSMD, OSDI, PSQI, SMD |
60 |
2022 |
Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease. |
5-DEQ, DED |
61 |
2022 |
Submandibular Gland Transplantation vs Minor Salivary Glands Transplantation for Treatment of Dry Eye: A Retrospective Cohort Study. |
BCVA, DED, FL, MSG, SMG, ST |
62 |
2022 |
Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm. |
BEB, BTX-A, CFSS, HFS, hRMS, OSDI, SA, TMH |
63 |
2022 |
Tear Neuromediators in Subjects with and without Dry Eye According to Ocular Sensitivity. |
CGRP, DE, NGF |
64 |
2022 |
The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye. |
HOAs, P-SE, S-SE |
65 |
2022 |
The effect of thermo-mechanical device (Tixel) treatment on evaporative dry eye disease - A pilot prospective clinical trial. |
CSS, DED, MGD, VA |
66 |
2022 |
The role of Meibomian glands on the development of dry eye disease in patients with unilateral pseudoexfoliation. |
OSDI, PEX |
67 |
2022 |
Therapeutic Effects of Topical Application of Lycium barbarum Polysaccharide in a Murine Model of Dry Eye. |
BAC, DED, DS, LBP, TNF-alpha |
68 |
2022 |
Tobacco effects on ocular surface, meibomian glands, and corneal epithelium and the benefits of treatment with a lipid-based lubricant. |
CET, CFS, LLT, MGD, SFA, SH |
69 |
2022 |
Transient effects of smoking on the eye. |
AoA, TMH |
70 |
2022 |
Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate. |
NZW, OAS |
71 |
2022 |
Wide Corneal Epithelial Thickness Mapping in Eyes With Topical Antiglaucoma Therapy Using Optical Coherence Tomography. |
CET, OCT, OSDI |
72 |
2021 |
A 4-week, randomized, double-masked study to evaluate efficacy of deproteinized calf blood extract eye drops versus sodium hyaluronate 0.3% eye drops in dry eye patients with ocular pain. |
CFS, DCBE, DED, OSDI, SH |
73 |
2021 |
A comparative assessment of dry eye disease among outdoor street sweepers and indoor office cleaners. |
DED, OSDI |
74 |
2021 |
A Hospital Based Study of Prevalence of Dry Eye in Tertiary Care Hospital of Nepal. |
OSDI |
75 |
2021 |
A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome. |
ATs, CI, DES, HA, SH, SMD |
76 |
2021 |
A multicenter cross-sectional survey of dry eye clinical characteristics and practice patterns in Korea: the DECS-K study. |
ADES, DEQS, OSDI, VDT |
77 |
2021 |
A Novel Multi-Ingredient Supplement Reduces Inflammation of the Eye and Improves Production and Quality of Tears in Humans. |
DES, MMP-9, OSDI, SPEED |
78 |
2021 |
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease. |
AE, DED, MGSS, OSDI |
79 |
2021 |
A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery. |
DES, DQS, HA, LLT, OSDI |
80 |
2021 |
A randomized multicenter clinical evaluation of sequential application of 0.3% and 0.15% hyaluronic acid for treatment of dry eye. |
CFS, DED, HA, OSDI |
81 |
2021 |
Alteration of corneal biomechanical properties in patients with dry eye disease. |
DED |
82 |
2021 |
Altered ocular surface immune cell profile in patients with dry eye disease. |
CS, DED, OS, OSDI, ST1 |
83 |
2021 |
Analysis of corneal densitometry and endothelial morphometry in patients with psoriasis. |
PASI |
84 |
2021 |
Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil. |
CFS, ChiCTR, MG, MGE, OSDI, SIT, TTO |
85 |
2021 |
Assessment of four validated questionnaires for screening of dry eye disease in an African cohort. |
MQ, OCI, OSDI |
86 |
2021 |
Association between functional status and ocular surface disease among local elderly population in Hong Kong. |
MGD, OSD, OSDI |
87 |
2021 |
Botulinum Toxin A Injection for the Treatment of Intractable Dry Eye Disease. |
BTA, DED, OSDI, TMH |
88 |
2021 |
Chambered warm moist air eyelid warming devices - a review. |
MGD, RCT |
89 |
2021 |
Changes in anterior segment parameters and presence of dry eye disease in patients with acromegaly: A Sirius topography study combined with meibography. |
ACD, ASPs, CV, DED, ICA, IOPGAT, MSs, OSDI, TCT, WTW |
90 |
2021 |
Changes in ocular surface and Meibomian gland after penetrating Keratoplasty. |
CFS, LLT, OSDI, PKP, SIT, TMA |
91 |
2021 |
Characteristics of dry eye patients with thick tear film lipid layers evaluated by a LipiView II interferometer. |
DED, LLT, OSDI, OSS |
92 |
2021 |
Clinical effectiveness of diquafosol ophthalmic solution 3% in Korean patients with dry eye disease: a multicenter prospective observational study. |
OSDI |
93 |
2021 |
Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension: a systematic review. |
IOP, RCTs |
94 |
2021 |
Comparative Study of Dry Eye Indices Following Cataract Surgery. |
LGSS, MSICS, OSDI |
95 |
2021 |
Comparative study on the effect of hyperthermic massage and mechanical squeezing in the patients with mild and severe meibomian gland dysfunction: An interventional case series. |
MGD, OSDI |
96 |
2021 |
Comparison of Autonomous AS-OCT Deep Learning Algorithm and Clinical Dry Eye Tests in Diagnosis of Dry Eye Disease. |
AS-OCT, DED, OSDI |
97 |
2021 |
Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. |
BAK, IOP, OHT, OSDI, POAG |
98 |
2021 |
Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial. |
IOP, OSDI |
99 |
2021 |
Comparison of tear proteomic and neuromediator profiles changes between small incision lenticule extraction (SMILE) and femtosecond laser-assisted in-situ keratomileusis (LASIK). |
LASIK, SMILE, SWATH-MS |
100 |
2021 |
Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking : Short term results. |
TMH |
|